New cholesterol drug tested in taiwan to help patients hit health goals
NCT ID NCT06925100
Summary
This study tested how well and how safely the cholesterol-lowering drug bempedoic acid works for people in Taiwan. It involved about 180 adults with high cholesterol who were not reaching their target cholesterol levels with their current medications. The main goal was to see how much the drug lowered 'bad' LDL cholesterol over 12 weeks of treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERCHOLESTEROLEMIA OR MIXED HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Far Eastern Memorial Hospital
New Taipei City, 220, Taiwan
-
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, 807, Taiwan
-
Linkou Chang Gung Memorial Hospital
Taoyuan District, 333, Taiwan
Conditions
Explore the condition pages connected to this study.